- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04488211
IVM Survey Among Reproductive Medicine Specialists
May 3, 2021 updated by: Universitair Ziekenhuis Brussel
Survey of Fertility Specialists' Knowledge of, Experience With, and Attitudes Toward the Use of in Vitro Maturation of Oocytes in Reproductive Medicine
Although IVM as a laboratory technology in reproductive medicine has existed for many decades, there is a lack of well-designed studies comparing the efficiency and the patient satisfaction related to IVM as compared to standard ovarian stimulation for IVF.
In view of this, and in order to identify unmet needs of fertility specialists with regard to the application of IVM, the investigator developed the idea of a worldwide web-based survey analysis of fertility specialists' insights and experiences regarding IVM.
Study Overview
Detailed Description
The IVM survey will be structured as a series of open questions and multiple-choice questions.
In most of the questions, a single answer will be required by participants.
A small number of questions will allow multiple answers.
The survey will be web-based.
Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic.
Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence.
When no response is obtained from selected fertility specialists, e-mails will be sent to affiliated colleagues working at the same fertility clinic.
When analyzing the survey results, care will be taken to analyse the responses per fertility clinic, as responses from different fertility specialists working in the same fertility clinic should be avoided.
Results will be analysed using a method that assigns equal weight per clinic and a method that weights clinic responses based on treatment volume (number of IVF cycles).
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussel, Belgium
- Universitair Ziekenhuis Brussel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Fertility specialists around the globe who are affiliated to a public or private fertility clinic.
Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence.
Description
Inclusion Criteria:
- IVF clinics that have worked with IVM previously but stopped
- clinics with appropriate size to offer IVM
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Prospective survey respondents
Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic.
|
The IVM survey will be structured as a series of open questions and multiple-choice questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Name of the measurement: Application of in vitro maturation (IVM) of oocytes as a laboratory tool
Time Frame: 1 month
|
Measurement tool: questionnaire; unit of measure: % of respondents who use oocyte in vitro maturation in the laboratory;
|
1 month
|
|
Name of the measurement: Appreciation of IVM as a laboratory technique
Time Frame: 1 month
|
Measurement tool: questionnaire; unit of measure: % of respondents who believe there is a role for IVM in the ART (assisted reproductive technology ) clinic
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Name of the measurement: Annual number of egg retrievals for IVM
Time Frame: 1 month
|
Measurement tool: questionnaire; unit of measure: number
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 30, 2020
Primary Completion (ACTUAL)
December 31, 2020
Study Completion (ACTUAL)
December 31, 2020
Study Registration Dates
First Submitted
July 6, 2020
First Submitted That Met QC Criteria
July 23, 2020
First Posted (ACTUAL)
July 27, 2020
Study Record Updates
Last Update Posted (ACTUAL)
May 4, 2021
Last Update Submitted That Met QC Criteria
May 3, 2021
Last Verified
June 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- IVM Survey V2 04062020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IVM
-
Northwestern UniversityTerminated
-
Mỹ Đức HospitalCompleted
-
Mỹ Đức HospitalCompleted
-
Mỹ Đức HospitalCompleted
-
Mỹ Đức HospitalCompleted
-
Mỹ Đức HospitalRecruiting
-
Mỹ Đức HospitalCompleted
-
Mỹ Đức HospitalCompleted
-
Mỹ Đức HospitalCompletedInfertility | IVF | Development, Child | IVMVietnam
-
Mỹ Đức HospitalVrije Universiteit BrusselRecruitingPCOS (Polycystic Ovary Syndrome) | Cumulus Cell | Capacitation IVM | Transcriptomic ProfilingVietnam
Clinical Trials on Survey
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad JaverianaCompletedNoncommunicable Diseases | Surveys and QuestionnairesColombia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Université de Cergy PontoiseCompleted
-
Sarasota Memorial Health Care SystemEnrolling by invitation
-
Ohio State UniversityWithdrawnMedicare Part DUnited States
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health InstituteCompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
Lawson Health Research InstituteCompletedEvaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation ParticipationMyocardial Infarction | Unstable Angina | Coronary Angioplasty | Coronary Artery Bypass SurgeryCanada
-
University GhentCompletedStroke | Upper Extremity Paresis | Survey